Yahoo
NasdaqCM - Nasdaq Real Time Price USD

MoonLake Immunotherapeutics (MLTX)

11.78 -0.79 (-6.28%)
At close: October 30 at 4:00:01 PM EDT
11.78 0.00 (0.00%)
After hours: October 30 at 4:00:14 PM EDT
Trade MLTX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
268,336
244,834
143,091
54,123
65,061.42
Operating Income
-268,336
-244,834
-143,091
-54,123
-65,061.42
Net Non Operating Interest Income Expense
-10,093
-7,248
0
0
--
Other Income Expense
14,282
22,372
22,129
10,138
591.73
Pretax Income
-264,147
-229,710
-120,962
-43,985
-64,469.69
Tax Provision
1,076
611
282
94
36.37
Net Income Common Stockholders
-263,666
-227,318
-118,936
-36,007
-49,973.25
Diluted NI Available to Com Stockholders
-263,666
-227,318
-118,936
-36,007
-49,973.25
Basic EPS
-3.84
-3.53
-1.89
-0.73
-1.28
Diluted EPS
-3.84
-3.53
-1.89
-0.73
-1.28
Basic Average Shares
69,135.58
64,463.89
62,870.24
49,122.53
38,977.60
Diluted Average Shares
69,135.58
64,463.89
62,870.24
49,122.53
38,977.60
Total Operating Income as Reported
-268,336
-244,834
-143,091
-54,123
-65,061.42
Total Expenses
268,336
244,834
143,091
54,123
65,061.42
Net Income from Continuing & Discontinued Operation
-263,666
-227,318
-118,936
-36,007
-49,973.25
Normalized Income
-263,317.40
-227,318
-118,936
-36,007
-49,973.25
Interest Expense
10,093
7,248
0
0
--
Net Interest Income
-10,093
-7,248
0
0
--
EBIT
-254,054
-222,462
-120,962
-43,985
-65,061.42
EBITDA
-250,817
-219,846
-119,577
-43,615
-64,896.63
Reconciled Depreciation
3,237
2,616
1,385
370
164.78
Net Income from Continuing Operation Net Minority Interest
-263,666
-227,318
-118,936
-36,007
-49,973.25
Total Unusual Items Excluding Goodwill
-581
--
--
--
--
Total Unusual Items
-581
--
--
--
--
Normalized EBITDA
-250,236
-219,846
-119,577
-43,615
-64,896.63
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-232.40
0
0
0
0
12/31/2022 - 10/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: